Loading...
TOL is not a good buy right now for an impatient buyer. Price is below the key pivot (146.11) with a weakening momentum setup (MACD histogram negative and expanding) ahead of the Feb 18 earnings catalyst, while fundamentals show margin/income pressure. If you must act immediately, the risk/reward is not favorable versus waiting for either a cleaner bounce off ~142.5 support or a reclaim of 146–150 resistance. Net: hold off on buying at current levels.
Trend/structure is mixed-to-cautious near term. The moving average stack is still bullish (SMA_5 > SMA_20 > SMA_200), which supports the bigger-picture uptrend, but momentum is deteriorating: MACD histogram is -0.216 and negatively expanding, signaling increasing downside momentum. RSI(6) ~48 is neutral, implying no oversold edge to buy immediately. Key levels: pivot 146.11 (current price ~144.7 is below it), support S1 142.53 then S2 140.31; resistance R1 149.69 then R2 151.91. With price under the pivot and MACD worsening, the path of least resistance is a test of 142.5 before a durable rebound.
Intellectia Proprietary Trading Signals
Pattern-based forward view provided: ~40% chance of -0.24% next day, +3.8% next week, -5.1% next month (tilts choppy/soft over a month).

Latest quarter: 2025/Q4. Revenue grew to $3.423B (+2.70% YoY), but profitability weakened: net income $446.7M (-6.04% YoY), EPS 4.58 (-1.08% YoY), and gross margin 25.48% (-3.56% YoY). The key takeaway is modest top-line growth but deteriorating margins/earnings—consistent with a more promotional/competitive environment and aligns with several analysts cutting FY26 expectations.
Recent Street trend: December 2025 featured multiple price target cuts after earnings/guidance (JPM to $141, Citi to $141, RBC to $144, GS to $140, KBW to $143), reflecting softer margin/outlook concerns. Since then, tone improved at the start of January: Citizens initiated Outperform with a $175 target (Jan 7) and BofA raised its target to $160 and reiterated Buy (Jan 16). Overall, ratings skew constructive (several Buys/Outperforms remain), but the dominant near-term message is “fundamentals may be pressured through 2026,” with valuation/supportive positioning as the main pro.
Wall Street pros: higher-end demand base perceived as less rate sensitive; history of execution (deliveries often above midpoint); shareholder returns; some see 2026 improving. Wall Street cons: margin compression/incentives; softer housing market; higher inventory/competition; 2026 seen as a reset year; multiple PT cuts signal tempered expectations.
Politician/congress trades: No recent congress trading data available in the last 90 days.